Get research updatesDepression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
Investigation of the effect and cost-effectiveness of nutrition education facilitated through an mHealth program on depressive symptoms in adults.
This study was withdrawn before enrollment.
In Australia
Effectiveness of ketamine therapy among patients with treatment-resistant depression: a double-blind, randomised, controlled trial
This study has finished and is no longer accepting participants.
In AustraliaThis study isn't currently recruiting.
In United Kingdom
This study isn't currently recruiting.
In Finland
The effects of erythropoietin on depressive symptoms and neurocognitive deficits in patients with treatment resistant depression and in patients with remitted bipolar disorder – a proof of concept ...
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In DenmarkThis study evaluated the safety and effectiveness of Liafensine for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including HuntsvilleA Single Dose, Randomized, Placebo Controlled Phase I Study on the Effects of BI 1358894 on Functional MRI Measurements in an Emotional Processing Paradigm in Patients With Major Depressive Disorder
This study has finished and is no longer accepting participants.
In BerlinResearchers are comparing Rapastinel and placebo to find out how the approaches affect depression symptoms in adults with depression.
This study ended early.
Multiple locations, including BirminghamThis study evaluated the safety and effectiveness of JNJ-67953964 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonResearchers compared 5 mg BI 1569912, 10 mg BI 1569912, 20 mg of BI 1569912 and placebo to find out how the approaches affected depression symptoms in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BellflowerResearchers compared BI 1358894, placebo and Quetiapine to find out how the approaches affected depression symptoms in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamThis study evaluates the safety and effectiveness of Psilocybin for people with depression.
Current recruitment status is unconfirmed.
Multiple locations, including Palo AltoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.